All Veoza articles
-
Industry news
Non-hormonal menopause drug approved in UK
The MHRA has authorised a non-hormonal medicine, Veoza, which targets a protein in the brain to stop vasomotor symptoms in menopause.
2024-01-04T10:27:00Z
The MHRA has authorised a non-hormonal medicine, Veoza, which targets a protein in the brain to stop vasomotor symptoms in menopause.
The peer-reviewed journal, published 11 times per year and available free to TOPRA members.
The Organisation for Professionals in Regulatory Affairs
TOPRA office
TOPRA Publishing, 6th Floor, 3 Harbour Exchange, South Quay, London E14 9GE, UK
Tel: +44 (0) 20 7510 2560
Email: publications@topra.org
TOPRA AISBL
Blvd du Souverain 280, 1160 Brussels, Belgium
Tel: +32 (0) 2 808 72 70
Site powered by Webvision Cloud